Cargando…

Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals

BACKGROUND: To identify best practices and quality improvement initiatives, we aimed to assess whether the incidence of Periprosthetic Joint Infection (PJI) and treatment strategies differed across patients treated in Australian, European and United States (US) hospitals. METHODS: Routinely collecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Marang-van de Mheen, Perla J., Bragan Turner, Ellie, Liew, Susan, Mutalima, Nora, Tran, Ton, Rasmussen, Sten, Nelissen, Rob G. H. H., Gordon, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441102/
https://www.ncbi.nlm.nih.gov/pubmed/28532409
http://dx.doi.org/10.1186/s12891-017-1569-2
_version_ 1783238197721956352
author Marang-van de Mheen, Perla J.
Bragan Turner, Ellie
Liew, Susan
Mutalima, Nora
Tran, Ton
Rasmussen, Sten
Nelissen, Rob G. H. H.
Gordon, Andrew
author_facet Marang-van de Mheen, Perla J.
Bragan Turner, Ellie
Liew, Susan
Mutalima, Nora
Tran, Ton
Rasmussen, Sten
Nelissen, Rob G. H. H.
Gordon, Andrew
author_sort Marang-van de Mheen, Perla J.
collection PubMed
description BACKGROUND: To identify best practices and quality improvement initiatives, we aimed to assess whether the incidence of Periprosthetic Joint Infection (PJI) and treatment strategies differed across patients treated in Australian, European and United States (US) hospitals. METHODS: Routinely collected administrative data for 41397 patients undergoing a primary total hip or knee arthroplasty between July 2007-December 2010 across 22 hospitals were included. Patients were followed for 2 years looking for PJI occurrence, defined as early (within 4 weeks) and late PJI, and surgical treatment during 2.5 years after PJI diagnosis. Logistic and Poisson regression models were used to test for differences in PJI occurrence and treatment strategies across the three geographical regions, adjusted for age, sex, joint and Elixhauser comorbidity groups. RESULTS: PJI occurrence varied from 1.4% in European to 1.7% in Australian patients, which were significantly higher than US patients after adjustment for patient characteristics (OR 1.24 [1.01–1.52] and 1.40 [1.03–1.91] respectively). Early PJIs varied between 0.3% in European to 0.6% in Australian patients, but adjusted rates were similar. Revision following PJI was significantly lower in Australian than in US patients (OR 0.46 [0.25–0.86]) as were the total number of revisions (RR 0.51 [0.36–0.71]) and number of surgical procedures (RR 0.60 [0.44–0.81]) used to treat PJI. CONCLUSION: The overall PJI rate was significantly higher in Australian patients, but fewer procedures were needed to treat these PJIs. Future research should reveal whether this reflects PJIs caught earlier or less severe when diagnosed, and whether this is associated with the longer length of stay after primary arthroplasty in Australian hospitals. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12891-017-1569-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5441102
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54411022017-05-24 Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals Marang-van de Mheen, Perla J. Bragan Turner, Ellie Liew, Susan Mutalima, Nora Tran, Ton Rasmussen, Sten Nelissen, Rob G. H. H. Gordon, Andrew BMC Musculoskelet Disord Research Article BACKGROUND: To identify best practices and quality improvement initiatives, we aimed to assess whether the incidence of Periprosthetic Joint Infection (PJI) and treatment strategies differed across patients treated in Australian, European and United States (US) hospitals. METHODS: Routinely collected administrative data for 41397 patients undergoing a primary total hip or knee arthroplasty between July 2007-December 2010 across 22 hospitals were included. Patients were followed for 2 years looking for PJI occurrence, defined as early (within 4 weeks) and late PJI, and surgical treatment during 2.5 years after PJI diagnosis. Logistic and Poisson regression models were used to test for differences in PJI occurrence and treatment strategies across the three geographical regions, adjusted for age, sex, joint and Elixhauser comorbidity groups. RESULTS: PJI occurrence varied from 1.4% in European to 1.7% in Australian patients, which were significantly higher than US patients after adjustment for patient characteristics (OR 1.24 [1.01–1.52] and 1.40 [1.03–1.91] respectively). Early PJIs varied between 0.3% in European to 0.6% in Australian patients, but adjusted rates were similar. Revision following PJI was significantly lower in Australian than in US patients (OR 0.46 [0.25–0.86]) as were the total number of revisions (RR 0.51 [0.36–0.71]) and number of surgical procedures (RR 0.60 [0.44–0.81]) used to treat PJI. CONCLUSION: The overall PJI rate was significantly higher in Australian patients, but fewer procedures were needed to treat these PJIs. Future research should reveal whether this reflects PJIs caught earlier or less severe when diagnosed, and whether this is associated with the longer length of stay after primary arthroplasty in Australian hospitals. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12891-017-1569-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-22 /pmc/articles/PMC5441102/ /pubmed/28532409 http://dx.doi.org/10.1186/s12891-017-1569-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Marang-van de Mheen, Perla J.
Bragan Turner, Ellie
Liew, Susan
Mutalima, Nora
Tran, Ton
Rasmussen, Sten
Nelissen, Rob G. H. H.
Gordon, Andrew
Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_full Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_fullStr Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_full_unstemmed Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_short Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_sort variation in prosthetic joint infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across australian, european and united states hospitals
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441102/
https://www.ncbi.nlm.nih.gov/pubmed/28532409
http://dx.doi.org/10.1186/s12891-017-1569-2
work_keys_str_mv AT marangvandemheenperlaj variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT braganturnerellie variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT liewsusan variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT mutalimanora variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT tranton variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT rasmussensten variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT nelissenrobghh variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT gordonandrew variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals